title: HBV infectivity among Nigerians.
abstract: The study involved 60 (non-immunized), 14 (immunized against HBV), healthy Nigerian adults and 28 Nigerian patients with hepatitis. Their sera were tested for HBsAg, HBeAg, anti-HBe, anti-HBc, anti-HBs and anti-HCV while only 15 subjects with chronic hepatitis had HBV DNA assay by PCR. The subjects aged 21 to 72 years and comprised 75 male and 27 female adults. The prevalence of HBV infection by HBsAg and/or anti-HBc sero-positivity was 55.9%. Only HBsAg and anti-HBs were detectable in 21% each among immunized while HBsAg, HBeAg, anti-HBe, anti-HBc, anti-HBs were present in 58%, 20%, 6%, 32%, and 42% respectively in the non-immunized subjects. HBV DNA was positive in 86.7% of the 15 subjects. About fifty five percent of all subjects were infectious of HBV with 13.7%, 3.9%. 32.3% and 4.9% accounting for high, medium, low and very low infectivity respectively while 44.1% and 1% of the subjects were susceptible and naturally immuned to HBV respectively. Coinfection with HCV tends to favour HBV infectivity. In conclusion, the infectivity of HBV among Nigeria is varied but high and a great proportion of the population is susceptible.
authors.affiliation: Department of Medicine, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria. soola@comui.edu.ng
authors.forename: S O
authors.initials: SO
authors.lastname: Ola
authors.forename: J A
authors.initials: JA
authors.lastname: Otegbayo
authors.forename: G N
authors.initials: GN
authors.lastname: Odaibo
authors.forename: D O
authors.initials: DO
authors.lastname: Olaleye
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D060085:Coinfection / Q000453:epidemiology / Q000276:immunology; D004279:DNA, Viral; D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006508:Hepatitis Antibodies / Q000032:analysis / Q000145:classification; D018963:Hepatitis Antigens / Q000032:analysis / Q000145:classification; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology; D006801:Humans; D007114:Immunization / Q000379:methods / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D009549:Nigeria / Q000453:epidemiology; D016133:Polymerase Chain Reaction; D015995:Prevalence; D017678:Sex Distribution
chemical_list: D004279:DNA, Viral; D006508:Hepatitis Antibodies; D018963:Hepatitis Antigens